Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds.
about
Rational methods for the selection of diverse screening compoundsComputational prediction and validation of an expert's evaluation of chemical probesAnalysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis.Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.Cheminformatics aspects of high throughput screening: from robots to models: symposium summaryHigh-throughput screen of natural product libraries for hsp90 inhibitors.Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study.Serendipity in anticancer drug discoverySize estimation of chemical space: how big is it?In Silico ADME/Tox PredictionsVirtual screening for novel Atg5–Atg16 complex inhibitors for autophagy modulation
P2860
Q28303907-E16AD7B6-7CB4-4D37-B2FC-B0A04B8B5AC2Q28829404-4ADD3569-6601-41CC-935A-039A93CE6CD2Q33690587-15674CD0-931D-4851-9EC4-88CF20B80421Q33717398-B8686E6A-E914-4E5E-94D8-E954B5CF1FB0Q34380828-A4E73020-F8EA-4713-ABDA-CBA7CAF3F182Q35169647-8501DC4A-389D-409A-B44C-B3C771461038Q36091191-3DA0C635-5D9F-412C-9429-28F67917FDDDQ40368701-04549A86-AF55-4FF0-B27C-7B14CA090BBBQ47321477-F3983298-D669-4179-B0AF-809381280AFBQ56984194-321E2239-595C-42D3-BD03-49FD65DFD2A3Q58176736-3F47B400-5A33-47B1-8193-0B5C31F1C08D
P2860
Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Investigation of the incidence ...... es in marketed drug compounds.
@ast
Investigation of the incidence ...... es in marketed drug compounds.
@en
type
label
Investigation of the incidence ...... es in marketed drug compounds.
@ast
Investigation of the incidence ...... es in marketed drug compounds.
@en
prefLabel
Investigation of the incidence ...... es in marketed drug compounds.
@ast
Investigation of the incidence ...... es in marketed drug compounds.
@en
P2093
P1476
Investigation of the incidence ...... es in marketed drug compounds.
@en
P2093
Amin Mirza
Ivan P Castañeda
Jóhannes Reynisson
Peter Axerio-Cilies
P304
P356
10.1016/J.EJMECH.2008.06.013
P577
2008-06-26T00:00:00Z